Skechers is an American footwear company founded in California in 1992, and in India it runs about 450 stores selling shoes at an MRP of roughly ₹5,000 to ₹10,000 — though almost nobody pays that. It is the fourth-largest sportswear business in India by filed revenue, it was taken private by 3G Capital in September 2025, and in 2012 it paid $40 million to settle a regulator’s finding that it had sold customers a health claim it could not support. Both halves of that sentence are the brand.
Skechers is an American comfort-footwear company, private since September 2025, and the fourth-largest sportswear business in India by filed revenue at about ₹1,970 crore. Its Indian MRP sits at or above US list, and it then discounts 30–40% almost permanently — so a ₹7,999 GO WALK usually transacts at ₹4,799. Comfortable shoes, honest fit, but treat the MRP as an anchor rather than a price.
Snapshot
- Founded
- 1992, Manhattan Beach, California, USA
- Founder
- Robert Greenberg, with his son Michael Greenberg
- Headquarters
- Manhattan Beach, California, USA
- Current owner
- 3G Capital, since 12 September 2025. Delisted from the NYSE; the Greenberg family took equity in the private parent and still runs the company
- Global revenue
- $8.97 billion in 2024, the last full year reported publicly. No figures published since
- India entity
- Skechers South Asia Private Limited, incorporated 11 April 2012, Mumbai
- In India since
- 2012, initially as a joint venture with Future Group; wholly owned since 2019
- Category
- Footwear
- Price band in India
- MRP ₹6,999 to ₹9,999 on the core comfort lines, but discounting of 30–40% is near-permanent, so the typical transacted price is ₹4,200 to ₹6,000
- Available in India
- Official — skechers.in, about 450 stores, and authorised marketplace storefronts
How it started
To understand Skechers you have to start with the company Robert Greenberg built before it, because Skechers is a direct response to how that one ended.
Greenberg founded LA Gear in 1983. It reached $820 million of sales in 1990 and was the third-largest athletic footwear brand in America behind Nike and Reebok; the stock went from $3 in 1986 to $50 in 1990. Then it collapsed. Greenberg had run hair salons, then a wig business, then imported jeans before any of this — he was a merchant who found footwear, not a shoemaker.
He started Skechers with his son Michael in 1992, and the company’s own account is that it began as a utility boot company. The first sneaker line, the Roadies, arrived in 1994 — a chunky utility silhouette, followed by Heartbeats and the Cleats Retro in 1996. Sources disagree on when the first store opened: Skechers’ own 2019 anniversary release says Manhattan Beach in 1995, while its executive-team page refers to the first store lease in 1994.
One thing we are not printing: the widely repeated gloss that “skechers” is slang for a young person on the move. It appears only on content farms and agency blogs, with no company statement or credible source behind it.
- LA GearFounded 1983; $820 million of sales by 1990
- The collapseStock and brand fall away after the 1990 peak
- SkechersStarted 1992 by Robert and Michael Greenberg
- Owned by 3G CapitalTaken private 12 September 2025 at $63 a share
The same family built both, which is why Skechers is run like a merchant’s business rather than a shoemaker’s.
The turning points
1999, the listing. Skechers went public on the NYSE on 9 June 1999 at $11.00 a share, with sales of $424.6 million that year. The structure created then is what mattered: Class A shares carried one vote, Class B ten. By mid-2002 the Greenberg family controlled roughly 92% of the votes on a fraction of the equity.
2005, the first billion. The company crossed $1 billion in annual sales.
2009–2011, Shape-ups. Toning shoes — rocker-soled footwear sold on the promise that walking in them would tone muscle and lose weight — produced a record quarter in early 2010 and then fell apart. By the first quarter of 2011 sales were down 3.4% and net earnings had collapsed from $56.3 million to $11.8 million year on year, with inventory up $187 million. Then the regulator arrived, which is a section of its own below.
2012 onwards, the recovery. This is the genuinely impressive part. Skechers replaced Shape-ups with GOwalk — the same customer, the same walking use case, a lightweight low-structure shoe with proprietary foams, and no health claim attached at all. By 2018 it was claiming the number one position in the US in walking, work, dress casual and casual lifestyle, on $4.64 billion of sales.
2011 and 2023, the credibility purchases. GOrun launched globally for the 2011 holiday season; the AERO Series with a carbon-infused plate followed in July 2025. Skechers Basketball launched on 25 October 2023, and OG Anunoby became the first player to win an NBA championship in Skechers. The first signature model, the SKX JE1 with Joel Embiid, was announced in December 2025. None of this is heritage; all of it is bought competence.
2025, going private. On 24 April 2025 Skechers withdrew its annual guidance, citing “macroeconomic uncertainty stemming from global trade policies” — tariffs, in plain words, with an analyst estimate putting 40–45% of its softlines manufacturing in China. Eleven days later, on 5 May, it agreed to be acquired by 3G Capital.
The Shape-ups settlement, in detail
This is the section that matters most on a site about fashion misinformation, because it is one of the few cases where a regulator did the work and published the findings.
What Skechers said. “Shape Up While You Walk.” “Get in Shape without Setting Foot in a Gym.” For the Resistance Runner it advertised specific muscle activation figures against ordinary running shoes: up to 85% for posture muscles, 71% for the buttocks, 68% for the calves.
What the Federal Trade Commission found. The clinical study Skechers presented as independent, run by a chiropractor, did not support the advertising claims — and Skechers failed to disclose that the researcher was married to a Skechers marketing executive and was paid by Skechers to conduct it. On the Resistance Runner advertising, the FTC found Skechers had cherry-picked results.
What it cost. A $40 million settlement on 16 May 2012, in a coordinated action with 44 state attorneys general plus the District of Columbia, Hawaii and Georgia. Of that, $5 million went to the states. A parallel class action settled the following year, with the same $40 million consumer fund plus $5 million in fees — so the total cash on the public record is $45 million, not $85 million as some accounts imply. The injunction bars unsubstantiated strengthening, weight-loss, calorie-burn, aerobic-conditioning and muscle-tone claims for toning shoes.
And what Skechers said two years earlier. On 26 August 2010 it put out a press release headlined that an independent review board had found the Shape-ups claims “substantiated by science” — citing four studies including the chiropractor’s. Its fitness division president was quoted saying: “Shape-ups advertising claims are substantiated by solid scientific testing, but the best substantiation is the sheer popularity of the shoe.”
That last clause is worth reading twice.
Popularity was being offered as evidence.
- 2009Toning shoes launched on a fitness claim
- 2010Press release calls the claims “substantiated by science”
- 2012$40 million FTC settlement, 16 May
- 2013Class action adds $5 million in fees
Total cash on the public record is $45 million, not the $85 million often quoted.
Who owns it now
3G Capital — the Brazilian-founded investment firm best known for Burger King and Kraft Heinz — agreed on 5 May 2025 to buy Skechers at $63.00 a share in cash, a 30% premium to the fifteen-day average, and completed on 12 September 2025. The shares no longer trade.
Two details are more interesting than the headline. First, the dual-class structure was dissolved on identical terms: both share classes got the same consideration “regardless of whether it is Class A or Class B shares”, so the family’s super-voting stock earned no control premium. Second, the Greenbergs did not cash out. They signed a support agreement committing to take the alternative Mixed Election — $57 in cash plus an unlisted, non-transferable equity unit in the new private parent — and Robert Greenberg remains chief executive with Michael Greenberg as president, in Manhattan Beach.
The deal was financed with roughly $8 billion of new debt, including $2.2 billion of payment-in-kind toggle notes at 10%, at around four times leverage. Press reports put the total value at $9.4 billion, $9 billion or $8.2 billion depending on the outlet; neither Skechers nor 3G ever published a total, only the per-share price. We are quoting the $63.00.
The practical consequence for anyone reading this: Skechers no longer reports its results. The last full public year is 2024 — $8.97 billion of sales, up 12.1%, net earnings of $639.5 million, 5,296 stores in 122 countries, about 20,100 employees. International was 62% of sales. Everything after mid-2025 is private.
How Skechers came to India
Skechers South Asia Private Limited was incorporated in Mumbai on 11 April 2012, and it entered as a joint venture with Kishore Biyani’s Future Group — Skechers 51%, Future 49%. In February 2019 Skechers bought out the Future stake and made India a wholly owned subsidiary. The price was never officially disclosed; Business Today reported around ₹600 crore, and a market database records roughly ₹5.8 billion. Both are on the record and they do not reconcile, so we are giving you both.
That buyout timing is worth noticing. Skechers took full control of its Indian business in early 2019, before Future Group’s own troubles began. Whatever else it got wrong, it got out of that partnership at the right moment.
The Indian business is now substantial. Registry data puts Skechers South Asia’s revenue at about ₹1,970 crore, up 11% in its most recent filed year — with a caveat we will state plainly: the same source shows its latest filed balance sheet as March 2024, so the year label is not fully confirmed. For scale, India revenue was under $100 million in 2018 across about 120 outlets, and Skechers turned its first Indian profit in 2017.
It crossed 450 stores in India in July 2026, roughly a year after passing 400, across malls, high streets and airports with a deliberate push into smaller cities. Rahul Vira has been chief executive of the India business since at least 2019.
Where Skechers sits against the rest of the imported sneaker brands, on filed Indian entity revenue:
| Indian entity | Revenue | Year |
|---|---|---|
| Decathlon India | ₹4,133 crore | To March 2025 |
| Puma Sports India | ₹3,274 crore | Calendar 2023 |
| Adidas India Marketing | ₹3,259 crore | To March 2025 |
| Skechers South Asia | ₹1,970 crore | Latest filed |
| Nike India | ₹1,381 crore | To March 2025 |
Registry filings. Year-ends differ — Puma reports January to December, the others April to March — so the ranking is indicative rather than exact.
On manufacturing, Skechers is the odd one out among these brands. Its last public annual report puts production with independent contractors “primarily in Asia”, principally China and Vietnam, with no Indian manufacturing disclosed. What it does have here is a distribution centre of about 0.8 million square feet outside Mumbai on a lease running to 2043. It was reported in 2018 to be working towards an Indian factory; we found no evidence it happened. It did launch Skechers Cricket in 2024 with Ishan Kishan and Yastika Bhatia.
The models that matter
Skechers has almost no heritage silhouette equity — no Air Jordan, no Stan Smith, no Samba. What it has instead is comfort technology sold as a merchandising system: a named, trademarked feature attached to hundreds of ordinary-looking styles at a mid price.
| Line | The claim | What actually changed |
|---|---|---|
| Roadies, 1994 | — | The founding chunky utility silhouette, and the company’s commercial DNA |
| D’Lites | Skechers publicly claims it fathered the chunky “dad” sneaker trend, ahead of Balenciaga’s Triple S | Contested but not absurd — a footwear editor at Highsnobiety conceded clear similarities. It is Skechers’ only genuine style-heritage asset, and it was claimed retrospectively in 2018 |
| Shape-ups, 2009–11 | Tone muscle and lose weight by walking | Nothing. Adjudicated deceptive; cost $45 million |
| GOwalk | A lightweight walking shoe, no health claim | Real, and the product that saved the company. It sold the toning customer the same shoe with the lie removed |
| Arch Fit | “Podiatrist-certified”, built on 120,000 unweighted foot scans | Mixed. The moulded footbed is a real feature. But a podiatric association seal is an acceptance mark, not a clinical efficacy finding, and the scan figure is a company claim with no published methodology |
| Hands Free Slip-ins, from December 2021 | Step in without hands or bending down | Real, and the most important footwear innovation here in decades — a moulded heel that works as a built-in shoehorn. |
The pattern is worth stating directly. Two of these systems genuinely changed how a shoe works. One was a fraud. And one — Arch Fit — sits in between, leaning on medical-adjacent language that stops carefully short of a medical claim. Given what happened in 2012, that last category deserves scepticism rather than repetition.
What Skechers costs in India
Checked on skechers.in and skechers.com on 20 August 2026.
| Model | India MRP | India selling price |
|---|---|---|
| GO WALK 7 | ₹7,999 | ₹4,799 — 40% off |
| GO WALK 7 City Lights | ₹8,499 | ₹5,949 — 30% off |
| ARCH FIT 2.0 | ₹6,999 | ₹4,199 — 40% off |
| GO WALK Arch Fit 2 | ₹9,999 | — |
Comparable American models list at $89 to $135 — GOwalk 8 styles around $100 to $105, GOwalk Arch Fit 2.0 at $100. We are not converting those figures, because we could not pull a dated reference exchange rate we would stand behind, and a converted price without a dated rate is a guess dressed as arithmetic.
What can be said without conversion is the useful part. Indian MRP on the core comfort lines sits at or above US list on any plausible rate — and then Skechers India discounts it by 30 to 40% more or less permanently. On the day we checked, an “End-of-Season Sale” was running site-wide, and both models we priced were 40% off.
That makes the MRP a discount-anchoring device rather than a price. Nobody is expected to pay ₹7,999 for a GO WALK 7, and the ₹4,799 is the real number.
- GO WALK 7, Indian MRP
- ₹7,999
- GO WALK 7, actual selling price
- ₹4,799
- Gap
- 40% off, running site-wide
- Checked on
- 20 August 2026
Who Skechers is actually for
Skechers is for the person who wants to be comfortable and has stopped caring whether the shoe is cool. That is a much larger group than the sneaker industry has ever wanted to serve, and Skechers built an $8.97 billion business on it while Nike and adidas marketed to eighteen-year-olds.
Specifically, it is the best mainstream option in India for three groups the category ignores: people on their feet all day, people who need a wide fit, and anyone who struggles to bend down and pull on a shoe. The Hands Free Slip-ins line is a genuine accessibility product being sold at ordinary retail without being medicalised or priced as a medical device, and that is unusual enough to be worth crediting.
Skip Skechers if you want performance. The AERO running series and the basketball line have real specification on paper, but you are buying an untested reputation at a price where Asics and Nike have decades of evidence. Skip it too if you want anything to hold its value or read as a style choice — this is a shoe that does a job.
And never, under any circumstances, pay the MRP.
Reputation and controversies
The toning settlement is set out in full above. It is the central fact about this company’s relationship with truth in advertising, and no account of Skechers that omits it is complete.
Copying, repeatedly litigated. This is a pattern rather than an incident, so here it is in sequence. In 2018 the Ninth Circuit upheld a preliminary injunction against Skechers’ Onix shoe on adidas’s unregistered Stan Smith trade dress, while reversing on a second model for want of irreparable harm; the wider adidas case settled that year on undisclosed terms. A Nike suit brought in 2016 over Flyknit design patents, later extended to VaporMax and Air Max 270 claims, settled confidentially in November 2021.
Forced labour. In June 2024 the US Department of Homeland Security added Dongguan Oasis Shoes and Dongguan Luzhou Shoes to the entity list barring imports under the Uyghur Forced Labor Prevention Act; Skechers said it did not expect a material impact. Underlying that is real concentration risk: one manufacturer accounted for 20.4% of purchases and the top five for 42.4%.
Counterfeiting in India, with Skechers as plaintiff. In October 2024 the Bombay and Delhi High Courts granted ex parte injunctions with search and seizure, and roughly 2,500 counterfeit items were seized across more than fifteen locations in Nashik, Indore and Delhi, timed just before Diwali.
One Indian legal footnote worth correcting. Skechers South Asia obtained an advance ruling from the customs authority in Mumbai in 2021, holding that imported footwear with a sale value up to ₹1,000 a pair attracted 5% IGST. That ruling is now spent — the threshold and rates have changed twice since — and anyone citing it as current Indian tax guidance is wrong.
What it gave footwear
The case against Skechers is easy and largely correct. It has no cultural equity. Its most-documented moments are ones in which a regulator found it had misled consumers or a court found it had likely copied a competitor. Its single heritage claim — that D’Lites founded the chunky sneaker trend — is a claim it made about itself in 2018, after Balenciaga had made chunky expensive.
The case for is narrower and more interesting, and it comes down to three things.
It made comfort a category instead of an apology. Before Skechers, a comfortable shoe was a medical or geriatric product sold quietly in specialist shops. Skechers named and trademarked comfort as a feature system — Memory Foam, GOwalk, Max Cushioning, Arch Fit — attached it to hundreds of ordinary-looking styles at a mid price, and put it in more than 5,000 stores. Every mainstream brand now sells a maximum-cushion everyday shoe. Skechers got there by treating comfort as the product rather than the compromise.
It built a real accessibility product and sold it as an ordinary one. The hands-free slip-in mechanism is a genuine mechanical change to how a shoe is put on, and its primary beneficiaries are people with arthritic hands, limited mobility, back pain or a pregnancy. That it is sold at normal retail rather than as a medical device is the achievement.
It served the customer the industry refused to see. While its competitors spent forty years marketing to an eighteen-to-thirty-four aspiration, Skechers sold to walkers, nurses, people on their feet, people who wanted a wide fit — and became the world’s number three athletic footwear company without a single endorsement athlete for most of that run.
That last insight is also exactly what made Shape-ups possible: an under-served, under-respected customer who wanted to be told her walk was worth something. Skechers found her honestly with GOwalk and dishonestly with Shape-ups, and made money both times. Both facts belong in the same paragraph, which is why we have put them there.
Buying it in India
Buy from skechers.in, a Skechers store, or the official brand storefronts on Amazon, Flipkart, Myntra, Ajio, Tata CLiQ and Nykaa Fashion. Skechers runs both company-owned and franchise stores here and both are authorised.
Counterfeit risk is real and has been enforced against — the 2024 seizures ran to about 2,500 items across three cities. The tells on a GOwalk or Arch Fit: a midsole that compresses too easily under thumb pressure, a printed rather than moulded logo on the heel, an insole that lifts without the Skechers branding underneath, uneven glue at the midsole join, and a style code on the box that does not match the tongue label. Five checks, in the order they are worth doing.
Press the midsole
Thumb pressure should meet resistance and spring back. A midsole that dents easily is cheap foam, and it is the fastest test there is.
The heel logo
The heel branding is moulded on a genuine pair. A printed logo that you can feel as ink rather than shape is a fake.
Lift the insole
Skechers branding is printed under the insole. A blank footbed underneath means the shoe was not built in an authorised factory.
The glue line
Run a finger around the join between upper and midsole. Uneven or squeezed-out adhesive is the commonest fault on copies.
Price against skechers.in
A marketplace seller offering a current model below the brand site’s own sale price is the strongest single warning. Skechers discounts hard already; nobody legitimately undercuts it.
There is no case for importing Skechers. Indian MRP is already at or above US list, and after the standing discount the transacted price here is competitive.
Common questions
Is Skechers still an American public company?
No. 3G Capital took Skechers private at $63.00 a share, completing on 12 September 2025, and it no longer trades on the NYSE. The Greenberg family took equity in the private parent rather than cashing out, and Robert Greenberg remains chief executive. Skechers has published no financial results since.
What happened with Skechers Shape-ups?
Skechers advertised that walking in them would tone muscle and help you lose weight. In May 2012 it paid $40 million to settle Federal Trade Commission charges of deceptive advertising, in a coordinated action with 44 state attorneys general. The FTC found the supposedly independent study did not support the claims and that its author was married to a Skechers marketing executive and paid by the company.
Why is Skechers always on sale in India?
Because the MRP is set high and discounted continuously. Both models we checked on 20 August 2026 were 40% off, during a site-wide end-of-season sale. Treat the discounted figure as the actual price, and never pay the sticker.
Is Skechers bigger than Nike in India?
On filed entity revenue, yes — about ₹1,970 crore against Nike India’s ₹1,381 crore. But that comparison flatters Skechers: Nike India Private Limited has around 41 employees and most of Nike’s Indian sales run through distributors outside that entity. Skechers is fourth in India behind Decathlon, Puma and adidas.
Are Skechers Arch Fit shoes medically approved?
No. A podiatric association seal is an acceptance mark, not a clinical finding of efficacy, and “podiatrist-certified” is marketing language rather than a regulatory status. The moulded footbed is a real feature and many people find it comfortable. Neither of those is a medical claim, and you should not treat it as one.
Does Skechers make shoes in India?
Not as far as its own disclosures show. Production is with contract manufacturers primarily in China and Vietnam. What Skechers has in India is a large distribution centre outside Mumbai on a lease to 2043, and about 450 stores.
References
- Skechers, 20 years on the NYSE, 5 June 2019 — 1992 founding, the 1999 listing at $11.00, first $1 billion year, category claims
- Fortune, 31 March 2003 — Robert Greenberg’s earlier businesses and LA Gear’s $820 million peak
- Skechers, 8 May 2019 — Roadies 1994, Heartbeats, Cleats Retro 1996
- Skechers Form S-3/A, SEC — the dual-class structure and the family’s ~92% of votes
- Skechers Q1 2011 results, SEC — the toning collapse: sales down 3.4%, earnings from $56.3m to $11.8m
- Federal Trade Commission, 16 May 2012 — the $40 million settlement, the advertising claims, and the undisclosed conflict of interest
- California Attorney General, 16 May 2012 — the 44-state action and the injunctive terms
- ClassAction.org — the $45 million class settlement and per-pair refund caps
- Skechers, 26 August 2010 — the “substantiated by science” release and the popularity-as-evidence quote
- Skechers and 3G Capital, 5 May 2025 — $63.00 a share, the Mixed Election, and the Greenberg support agreement
- Skechers, 12 September 2025 — completion, delisting, and management retained
- Kirkland & Ellis, September 2025 — the $8 billion financing structure
- Skechers Q1 2025, 24 April 2025 — guidance withdrawn over global trade policy
- Skechers FY2024 Form 10-K, SEC — $8.97 billion sales, store and employee counts, sourcing concentration, the Mumbai distribution centre, Skechers Cricket
- FashionNetwork India, 13 February 2018 — the Future Group joint venture at 51:49 and the 2018 India baseline
- Business Today, 13 February 2019 — the buyout of Future Group’s 49%
- Skechers South Asia Private Limited, MCA record — incorporation 11 April 2012, directors, revenue and headcount
- Indian Retailer, 22 July 2026 — crossing 450 stores in India
- IndiaRetailing, 18 November 2019 — Rahul Vira as India chief executive
- Skechers, on Hands Free Slip-ins — the moulded heel panel and Heel Pillow, and the intended users
- Skechers, on Arch Fit — the “podiatrist-certified” language and the 120,000 foot scans claim
- Quartz, 19 October 2018 — Skechers claiming paternity of the chunky sneaker trend
- adidas America v Skechers, Ninth Circuit, 10 May 2018 — injunction upheld on the Onix, reversed on the Cross Court
- Romano Law, 21 February 2022 — the 2016 Nike Flyknit suit and its confidential 2021 settlement
- Supply Chain Dive, 25 June 2024 — the supplier added to the forced-labour entity list and Skechers’ response
- Business Standard, 28 October 2024 — 2,500 counterfeit items seized across Nashik, Indore and Delhi
- Customs Authority for Advance Rulings, Mumbai, 2021 — the Skechers IGST ruling, now superseded
How we research and verify brand audits:
our methodology.
Skechers makes genuinely good comfort footwear and sells it in India at a real price of ₹4,000 to ₹6,000, which is fair. The GOwalk and the slip-in lines do what they say. If you are on your feet all day, or you cannot easily bend to put a shoe on, this is the most practical brand of the lot and it is not close.
What you should carry with you is the 2010 press release. Two years before a regulator established that its toning claims were unsupported and that its “independent” researcher was married to a company executive, Skechers publicly insisted the science was solid — and offered the shoe’s popularity as evidence. The company has not repeated that specific offence. But it now markets Arch Fit as “podiatrist-certified” on the strength of an association seal and 120,000 unnamed foot scans, and it prices everything at an MRP nobody pays. The instinct to say slightly more than the evidence supports has not gone anywhere.
Trust the shoe, which is good. Read the claim on the box twice, because this company has form.
